These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 21529996)
1. Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: a population-based case-control study. Torti DC; Christensen BC; Storm CA; Fortuny J; Perry AE; Zens MS; Stukel T; Spencer SK; Nelson HH; Karagas MR J Am Acad Dermatol; 2011 Aug; 65(2):304-312. PubMed ID: 21529996 [TBL] [Abstract][Full Text] [Related]
2. Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia. Pandeya N; Olsen CM; Thompson BS; Dusingize JC; Neale RE; Green AC; Whiteman DC; Br J Dermatol; 2019 Oct; 181(4):749-760. PubMed ID: 30920641 [TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer. Reinau D; Surber C; Jick SS; Meier CR Int J Cancer; 2015 Jul; 137(1):144-53. PubMed ID: 25418602 [TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study. Johannesdottir SA; Chang ET; Mehnert F; Schmidt M; Olesen AB; Sørensen HT Cancer; 2012 Oct; 118(19):4768-76. PubMed ID: 22644960 [TBL] [Abstract][Full Text] [Related]
5. Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial. Clouser MC; Roe DJ; Foote JA; Harris RB Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):276-83. PubMed ID: 19226541 [TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study. Jeter JM; Han J; Martinez ME; Alberts DS; Qureshi AA; Feskanich D Cancer Causes Control; 2012 Sep; 23(9):1451-61. PubMed ID: 22763500 [TBL] [Abstract][Full Text] [Related]
7. Effect of NSAIDs on the recurrence of nonmelanoma skin cancer. Grau MV; Baron JA; Langholz B; Karagas M; Greenberg ER; Stukel TA; Mandel JS Int J Cancer; 2006 Aug; 119(3):682-6. PubMed ID: 16496410 [TBL] [Abstract][Full Text] [Related]
8. Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma. Asgari MM; Chren MM; Warton EM; Friedman GD; White E Arch Dermatol; 2010 Apr; 146(4):388-95. PubMed ID: 20157019 [TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin. Butler GJ; Neale R; Green AC; Pandeya N; Whiteman DC J Am Acad Dermatol; 2005 Dec; 53(6):966-72. PubMed ID: 16310056 [TBL] [Abstract][Full Text] [Related]
10. Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study). Murad AS; Down L; Davey Smith G; Donovan JL; Athene Lane J; Hamdy FC; Neal DE; Martin RM Int J Cancer; 2011 Mar; 128(6):1442-8. PubMed ID: 20506261 [TBL] [Abstract][Full Text] [Related]
11. Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis. Muranushi C; Olsen CM; Pandeya N; Green AC J Invest Dermatol; 2015 Apr; 135(4):975-983. PubMed ID: 25521453 [TBL] [Abstract][Full Text] [Related]
12. Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas. Passarelli MN; Barry EL; Zhang D; Gangar P; Rees JR; Bresalier RS; McKeown-Eyssen G; Karagas MR; Baron JA Br J Dermatol; 2018 Aug; 179(2):337-344. PubMed ID: 29570772 [TBL] [Abstract][Full Text] [Related]
13. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study. Frieling UM; Schaumberg DA; Kupper TS; Muntwyler J; Hennekens CH Arch Dermatol; 2000 Feb; 136(2):179-84. PubMed ID: 10677093 [TBL] [Abstract][Full Text] [Related]
14. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer. Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591 [TBL] [Abstract][Full Text] [Related]
16. Personal history of psoriasis and risk of nonmelanoma skin cancer (NMSC) among women in the United States: A population-based cohort study. Dai H; Li WQ; Qureshi AA; Han J J Am Acad Dermatol; 2016 Oct; 75(4):731-735. PubMed ID: 27436157 [TBL] [Abstract][Full Text] [Related]
17. Use of nonsteroidal anti-inflammatory drugs and risk of basal cell carcinoma in the United States Radiologic Technologists study. Cahoon EK; Rajaraman P; Alexander BH; Doody MM; Linet MS; Freedman DM Int J Cancer; 2012 Jun; 130(12):2939-48. PubMed ID: 21780102 [TBL] [Abstract][Full Text] [Related]
18. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA; J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281 [TBL] [Abstract][Full Text] [Related]
19. Can oral nonsteroidal antiinflammatory drugs play a role in the prevention of basal cell carcinoma? A systematic review and metaanalysis. Muranushi C; Olsen CM; Green AC; Pandeya N J Am Acad Dermatol; 2016 Jan; 74(1):108-119.e1. PubMed ID: 26433247 [TBL] [Abstract][Full Text] [Related]
20. A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence. Asgari MM; Maruti SS; White E J Natl Cancer Inst; 2008 Jul; 100(13):967-71. PubMed ID: 18577752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]